Clinical Trial Update: Comparative Study of Dorzotimol Eye Drops, 20 mg/mL + 5 mg/mL Versus Cosopt® Eye Drops, 20 mg/mL + 5 mg/mL [Phase 3]

View source ↗

Summary

A Phase 3 comparative trial evaluating Dorzotimol Eye Drops (20 mg/mL + 5 mg/mL) versus Cosopt Eye Drops (20 mg/mL + 5 mg/mL) in primary open-angle glaucoma; st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Open-angle Glaucoma

Drugs mentioned

• Cosopt Eye Drops (dorzolamide-timolol)
• Dorzotimol Eye Drops (dorzotimol)

Snippet

Sponsor: Jadran Galenski laboratorij d.d. | Conditions: Primary Open Angle Glaucoma of Both Eyes | Phase 3 | Status: COMPLETED